FabK 단백질의 3차원 결정 구조, 및 이를 이용한FabK 단백질 저해제 개발 방법
    2.
    发明公开
    FabK 단백질의 3차원 결정 구조, 및 이를 이용한FabK 단백질 저해제 개발 방법 有权
    FABK蛋白质的三维结构及其使用方法开发FABK蛋白质抑制剂

    公开(公告)号:KR1020090072904A

    公开(公告)日:2009-07-02

    申请号:KR1020080012356

    申请日:2008-02-11

    Inventor: 김은경 하병학

    Abstract: A method for developing a FabK inhibitor is provided to screen a FabK inhibiting agent using active fragment of FabK and three dimensional structure. A method for crystallizing a FabK protein comprises a step of containing FabK protein solution with container solution comprising buffer solution, metal salt and precipitator. The concentration of FabK protein solution is 3-30mg/ml. The pH concentration and concentration is 4-9.5 and 0.005-1.5M. The metal salt is alkaline metal salt and alkaline metal salt. A precipitator is selected from alcohol of C1-4, and the concentration in the container solution is 1-40%(v/v). FabK-FMN(falvin mononucleotide) complex crystalline has three dimensional structure. A method for developing an inhibitor of FabK inhibitor is to use the three dimensional crystalline structure information.

    Abstract translation: 提供用于开发FabK抑制剂的方法,以使用FabK的活性片段和三维结构筛选FabK抑制剂。 用于结晶FabK蛋白的方法包括含有包含缓冲溶液,金属盐和除尘器的容器溶液的FabK蛋白溶液的步骤。 FabK蛋白溶液的浓度为3-30mg / ml。 pH浓度为4-9.5和0.005-1.5M。 金属盐是碱金属盐和碱金属盐。 沉淀器选自C1-4的醇,容器溶液中的浓度为1-40%(v / v)。 FabK-FMN(falvin单核苷酸)复合结晶具有三维结构。 开发FabK抑制剂抑制剂的方法是使用三维晶体结构信息。

Patent Agency Ranking